CSI Market
Sign In | Register

Champions Oncology Inc (CSBR) Annual Income Statement

Annual · GAAP · USD millions
Access CSBR quarterly income statements →
Reviewing income statement figures over time helps illustrate how Champions Oncology Inc generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Apr 30 2026)
2026 		(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax59.43
Total Revenue59.43
Costs & Expenses
Cost of Goods and Services Sold30.90
Gross Profit0.00
Selling, Administration, Marketing20.47
Depreciation & Amortization2.78
Research and Development Expense9.08
Impairment of Long-Lived Assets Held-for-use0.00
Other Operating Expense / -Income0.00
Total operating costs including COS0.00
Operating income / -loss-1.14
Net Interest Expense / -Income0.00
Other loss / -income0.00
Total costs & expenses0.00
Income & Taxes
Income / -loss before income taxes-0.93
Income taxes expenses / -benefit0.25
Income after income taxes-1.18
Net income / -loss of other equity0.00
Income / -loss from continuing operations-1.18
Net income / -loss-1.18
Income / -loss to shareholder-1.18
EBIT-0.93
EBITD0.21
EBITDA0.21
Earnings Per Share
Basic EPS (excl. extra items)-0.08
Basic Net EPS-0.08
Basic shares outstanding (Mill. of Units)13.83
Diluted Net EPS-0.08
Diluted average shares (Mill. of Units)13.83
4 historic quarters locked

Sign in to unlock the full Champions Oncology Inc income statement history.

Sign In Create Free Account

About Champions Oncology Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: July 27, 2026
  • Original filing: csbr-20260430.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.